Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Melanoma

Free Subscription Articles published in J Am Acad Dermatol Retrieve available abstracts of 235 articles: HTML format

Single Articles

October 2023
1. YUMEEN S, Mirza FN, Mirza HN, Zogg CK, et al
   Malignant blue nevus: Characterization of US epidemiology and prognostic factors of a rare neoplasm with aggressive clinical course using the Surveillance, Epidemiology, and End Results Program database.
   J Am Acad Dermatol. 2023;89:843-846.
   PubMed    
   
   
   
2. KRENGEL S, Ott H, Waelchli R
   Recommendations for routine magnetic resonance imaging in children with congenital melanocytic nevi need revision Comment to Neale et al., J Am Acad Dermatol. 87(5):1060-1068.
   J Am Acad Dermatol. 2023;89:e153-e154.
   PubMed    
   
   
   September 2023
3. WEI AH, Fane LS, Tripathi R, Bordeaux JS, et al
   Differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
   J Am Acad Dermatol. 2023 Sep 26:S0190-9622(23)02868.
   PubMed    
   
   
   
4. WEI AH, Zheng DX, Cullison CR, Scott JF, et al
   Incidence and characteristics of acral lentiginous melanoma in Asian Americans and Pacific Islanders.
   J Am Acad Dermatol. 2023 Sep 19:S0190-9622(23)02828.
   PubMed    
   
   
   
5. TAN SX, Aung TN, Claeson M, Acs B, et al
   Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study.
   J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02833.
   PubMed    
   
   
   
6. NI Y, Watts CG, Scolyer RA, Madronio C, et al
   Prognosis for people with multiple primary melanomas compared with a single primary melanoma.
   J Am Acad Dermatol. 2023 Sep 13:S0190-9622(23)02693.
   PubMed    
   
   
   
7. WU Q, Pan J, Lin W, Zhao S, et al
   Clinicopathologic features, delayed diagnosis and survival in amelanotic acral melanoma: a comparative study with pigmented melanoma.
   J Am Acad Dermatol. 2023 Sep 8:S0190-9622(23)02677.
   PubMed    
   
   
   
8. LIN JY, Wang J, Mishra K, Osmani S, et al
   Non-Melanoma Skin Cancer in Skin of Color Solid Organ Transplant Recipients.
   J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02678.
   PubMed    
   
   
   
9. GRANT-KELS JM
   JAAD Game Changers: Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
   J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02674.
   PubMed    
   
   
   
10. JILANI S, D'Amiano NM, Thompson KG, Ellis J, et al
    Factors Affecting Follow-Up Adherence Following Mohs Micrographic Surgery in Patients with Non-Melanoma Skin Cancer: A Retrospective Chart Review.
    J Am Acad Dermatol. 2023 Sep 5:S0190-9622(23)02669.
    PubMed    
    
    
    
11. KIM U, Hoehn R, Schwartz GK, Cullen J, et al
    Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02659.
    PubMed    
    
    
    
12. COSTELLO CM, Dusza SW, Marghoob AA, Halpern AC, et al
    Melanoma Screening and Public Education for Minority Populations in the United States.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02663.
    PubMed    
    
    
    
13. ANVERY N, Kang B, Christensen RE, Dirr MA, et al
    Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithms.
    J Am Acad Dermatol. 2023;89:595-597.
    PubMed    
    
    
    
14. CHOI S, Mulvaney P
    Evaluating the landscape of discount and patient assistance programs for topical sunscreen products in the United States.
    J Am Acad Dermatol. 2023;89:580-582.
    PubMed    
    
    
    August 2023
15. SORENSEN R
    Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
    J Am Acad Dermatol. 2023 Aug 26:S0190-9622(23)02633.
    PubMed    
    
    
    
16. XIONG DD, Bordeaux J
    The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: a retrospective national cohort study.
    J Am Acad Dermatol. 2023 Aug 23:S0190-9622(23)02595.
    PubMed     Abstract available
    
    
    
17. BRODELL RT
    Primary dermal melanoma: A unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: A clinical, histologic, and gene expression-profiling study.
    J Am Acad Dermatol. 2023 Aug 16:S0190-9622(23)02515.
    PubMed    
    
    
    
18. ROSTER K, Rajeh A, Wu F, Wan G, et al
    Recurrence and Survival in Early-stage Acral Lentiginous Melanoma, A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Aug 13:S0190-9622(23)02494.
    PubMed    
    
    
    
19. PAN CX, Lau WC, Kim DY, Lau CB, et al
    Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation.
    J Am Acad Dermatol. 2023 Aug 8:S0190-9622(23)02422.
    PubMed    
    
    
    
20. EL SHAROUNI MA, Lo SN, Scolyer RA, van Gils CH, et al
    Reply to: "Estrogen could also play a key role in the development of pediatric melanoma".
    J Am Acad Dermatol. 2023;89:e97-e98.
    PubMed    
    
    
    July 2023
21. AMARAL T, Pop OT, Chatziioannou E, Sinnberg T, et al
    EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
    J Am Acad Dermatol. 2023 Jul 22:S0190-9622(23)02392.
    PubMed    
    
    
    
22. FREEMAN SC, Munoz EP, Latour E, Lim JY, et al
    External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01350.
    PubMed     Abstract available
    
    
    
23. HOANG MP, Karpinski P, Zuniga-Castillo M, Foreman RK, et al
    Histologic Margin Status is a Predictor of Relapse in Lentigo Maligna Melanoma.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01349.
    PubMed     Abstract available
    
    
    
24. UGWU N, Cheraghlou S, Weiss J
    Primary Merkel Cell Carcinoma Is Associated with Increased, Extended Risk of Subsequent Melanoma and Non-Epithelial Skin Cancer.
    J Am Acad Dermatol. 2023 Jul 12:S0190-9622(23)01345.
    PubMed    
    
    
    
25. FERNANDEZ JM, Mata EM, Bubic BN, Kwan KR, et al
    Racial and ethnic differences in males with melanoma: A retrospective cohort study of 205,125 cases from the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 11:S0190-9622(23)01105.
    PubMed    
    
    
    
26. MUNOZ EP, Patel SP, Leachman SA, Yu NY, et al
    Minority Enrollment in Melanoma Clinical Trials.
    J Am Acad Dermatol. 2023 Jul 5:S0190-9622(23)01263.
    PubMed    
    
    
    
27. MEVES A, Todd A, Johnson EF
    Tumor width and calculated tumor area do not outperform Breslow thickness in predicting sentinel lymph node biopsy positivity.
    J Am Acad Dermatol. 2023;89:188-190.
    PubMed    
    
    
    
28. SMITH B, Smith JE, Demanelis K, Ferris LK, et al
    Changes in skin cancer screening rates in the United States from 2005 to 2015.
    J Am Acad Dermatol. 2023;89:142-145.
    PubMed    
    
    
    
29. MORGAN FC, Yehia L, McDonald C, Martinez-Agosto JA, et al
    Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
    J Am Acad Dermatol. 2023;89:90-98.
    PubMed     Abstract available
    
    
    June 2023
30. INGRASSIA JP, Adotama P, Stein JA, Polsky D, et al
    Re-examining melanoma secondary prevention and the role of skin self-examination.
    J Am Acad Dermatol. 2023 Jun 27:S0190-9622(23)01195.
    PubMed    
    
    
    
31. RYPKA KJ, Goldfarb N, Mansh M
    Response to the Feasibility of Kreher et al.'s "Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors".
    J Am Acad Dermatol. 2023 Jun 26:S0190-9622(23)01188.
    PubMed    
    
    
    
32. PAN CX, Nambudiri VE
    Response to: "Response to Pan et al.'s 'Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.'".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01099.
    PubMed    
    
    
    
33. BARRY R, Murray G, Hazel K, Ryan J, et al
    Response to Pan et al.'s "Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01100.
    PubMed    
    
    
    
34. ABRANTES T, Robbins A, Kahn B, Yumeen S, et al
    Understanding melanoma in situ - lentigo maligna surgical treatment terminology and guideline adherence, a targeted review.
    J Am Acad Dermatol. 2023 Jun 10:S0190-9622(23)01084.
    PubMed     Abstract available
    
    
    
35. CHANG ALS, Zaba L, Kwong BY
    Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments.
    J Am Acad Dermatol. 2023;88:1243-1255.
    PubMed     Abstract available
    
    
    
36. LEUNG BW, Wan G, Nguyen N, Rashdan H, et al
    Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study.
    J Am Acad Dermatol. 2023;88:1265-1270.
    PubMed     Abstract available
    
    
    May 2023
37. LIM RK, Weinstock MA
    Racial disparities in diagnosis of invasive melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results Program.
    J Am Acad Dermatol. 2023 May 29:S0190-9622(23)00985.
    PubMed    
    
    
    
38. RAJEH A, Wan G, Roster K, Rashdan H, et al
    Underuse of sentinel lymph node biopsy for early-stage melanoma.
    J Am Acad Dermatol. 2023 May 25:S0190-9622(23)00975.
    PubMed    
    
    
    
39. KO MJ, Tsai WC, Tsai PH, Hsu LY, et al
    Ultraviolet B Phototherapy Does Not Increase the Risk of Skin Cancer Among Patients with Atopic Dermatitis: A Population-Based Retrospective Cohort Study.
    J Am Acad Dermatol. 2023 May 24:S0190-9622(23)00977.
    PubMed     Abstract available
    
    
    
40. HEERFORDT IM, Philipsen PA, Andersen JD, Langhans L, et al
    RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00971.
    PubMed     Abstract available
    
    
    
41. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: a cross-sectional study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00969.
    PubMed     Abstract available
    
    
    
42. KIM DY, Marchetti MA, Hartman RI
    Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010-2019.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00905.
    PubMed    
    
    
    
43. YOUNG JN, O'Hagan R, Poplausky D, Levoska MA, et al
    The utility of ChatGPT in generating patient-facing and clinical responses for melanoma.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00908.
    PubMed    
    
    
    
44. ZHANG S, Tang K, Wan G, Nguyen N, et al
    Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
    J Am Acad Dermatol. 2023;88:1024-1032.
    PubMed     Abstract available
    
    
    
45. JOEL MZ, Tripathi R, Scott JF
    Predictors of receipt of sentinel lymph node biopsy in patients with malignant adnexal tumors of the skin.
    J Am Acad Dermatol. 2023;88:1179-1182.
    PubMed    
    
    
    
46. FELMINGHAM C, Pan Y, Kok Y, Kelly J, et al
    Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting.
    J Am Acad Dermatol. 2023;88:1138-1142.
    PubMed    
    
    
    
47. SHI K, Zhang B, Kong BY, Zhang Y, et al
    Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
    J Am Acad Dermatol. 2023;88:1051-1059.
    PubMed     Abstract available
    
    
    
48. CAI ED, Swetter SM, Sarin KY
    Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014.
    J Am Acad Dermatol. 2023;88:e211-e219.
    PubMed     Abstract available
    
    
    April 2023
49. AZOULAY L, St-Jean A, Dahl M, Quail J, et al
    Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multi-site population-based cohort study.
    J Am Acad Dermatol. 2023 Apr 25:S0190-9622(23)00735.
    PubMed     Abstract available
    
    
    
50. SHANNON AB, Karakousis GC
    The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to additional multi-institution and international reports.
    J Am Acad Dermatol. 2023 Apr 22:S0190-9622(23)00732.
    PubMed    
    
    
    
51. DRUMM C, Griffin C, Van Baarsel S, Quigley C, et al
    Response to Trepanowski et al.'s "Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study".
    J Am Acad Dermatol. 2023 Apr 21:S0190-9622(23)00733.
    PubMed    
    
    
    
52. CHOI ME, Yang HJ, Won CH, Chang SE, et al
    Differences in the Tumor Immunity-related Gene Expression Profile Between Acral Lentiginous and Non-acral Melanoma.
    J Am Acad Dermatol. 2023 Apr 19:S0190-9622(23)00712.
    PubMed    
    
    
    
53. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Disparities between Asian groups in time to melanoma treatment: a cross-sectional study.
    J Am Acad Dermatol. 2023 Apr 11:S0190-9622(23)00589.
    PubMed    
    
    
    
54. HARVEY JA, Smith JF, Berry NA, Butterfield RJ, et al
    The influence of dermoscopy education over 14 years at a single institution: A retrospective cohort study.
    J Am Acad Dermatol. 2023;88:906-908.
    PubMed    
    
    
    March 2023
55. CRUM OM, Campbell EH, Reinhart JP, Proffer SL, et al
    Incidence Trends of Melanoma among Young Adults: An Epidemiologic Study in Olmsted County, Minnesota.
    J Am Acad Dermatol. 2023 Mar 29:S0190-9622(23)00518.
    PubMed    
    
    
    
56. MATA EM, Trinidad N, Blue E, Lobl M, et al
    Disparities in melanoma outcomes in urban versus rural settings: An analysis from the Nebraska Cancer Registry 2001-2016.
    J Am Acad Dermatol. 2023 Mar 20:S0190-9622(23)00450.
    PubMed    
    
    
    
57. MAGNATERRA E, Zuccaro B, Magliulo M, Venturi F, et al
    Estrogen could also play a key role in the development of pediatric melanoma.
    J Am Acad Dermatol. 2023 Mar 18:S0190-9622(23)00439.
    PubMed    
    
    
    
58. LIN EM, Lim RK, Lin S, Cho E, et al
    Disparities in Asian American Melanoma Diagnosis and Treatment from 1990-2014 -- Response to Zheng et al. "Poor melanoma outcomes and survival in Asian American and Pacific Islander patients".
    J Am Acad Dermatol. 2023 Mar 9:S0190-9622(23)00357.
    PubMed    
    
    
    
59. KIM DY, Behbahani S, Hartman RI
    Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States.
    J Am Acad Dermatol. 2023 Mar 8:S0190-9622(23)00356.
    PubMed    
    
    
    
60. VERMARIEN-WANG J, Doeleman T, van Doorn R, Mooyaart AL, et al
    Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlan
    J Am Acad Dermatol. 2023;88:602-608.
    PubMed     Abstract available
    
    
    
61. TARANTINO IS, Kwak YJ, Goldberg LH, Beroukhim K, et al
    Application of a taped gauze on the gloved hand in preparation for a pressure bandage after a Mohs micrographic surgery layer.
    J Am Acad Dermatol. 2023;88:e125-e126.
    PubMed    
    
    
    
62. LEE K
    JAAD Game Changers *: The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis.
    J Am Acad Dermatol. 2023;88:749.
    PubMed    
    
    
    February 2023
63. IQBAL A, Bell MC, Merkel EA, Somani AK, et al
    The effect of tumor mitotic rate on melanoma-specific survival: A SEER population-based study of 54,598 cases.
    J Am Acad Dermatol. 2023 Feb 23:S0190-9622(23)00274.
    PubMed    
    
    
    
64. NGUYEN N, Wan G, Ugwu-Dike P, Alexander NA, et al
    Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
    J Am Acad Dermatol. 2023 Feb 22:S0190-9622(23)00204.
    PubMed     Abstract available
    
    
    
65. DESSINIOTI C, Plaka M, Kypreou K, Stergiopoulou A, et al
    A retrospective study of small-diameter invasive melanomas: metastasis at diagnosis and 9-year follow-up.
    J Am Acad Dermatol. 2023 Feb 21:S0190-9622(23)00267.
    PubMed    
    
    
    
66. STEPHENS MR, Asdourian MS, Jacoby TV, Shah N, et al
    Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
    J Am Acad Dermatol. 2023 Feb 15:S0190-9622(23)00193.
    PubMed    
    
    
    
67. WILSON BN, Shah R, Musthaq S, Vaidya T, et al
    Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma.
    J Am Acad Dermatol. 2023;88:440-442.
    PubMed    
    
    
    
68. NAVARRETE-DECHENT C, Cordova M, Aleissa S, Liopyris K, et al
    Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
    J Am Acad Dermatol. 2023;88:371-379.
    PubMed     Abstract available
    
    
    
69. LEE K
    JAAD Game Changers: Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
    J Am Acad Dermatol. 2023;88:517.
    PubMed    
    
    
    January 2023
70. YOUNG JN, Nguyen TA, Freeman SC, Hill E, et al
    Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: a retrospective dual-center analysis.
    J Am Acad Dermatol. 2023 Jan 28:S0190-9622(23)00141.
    PubMed     Abstract available
    
    
    
71. STULL CM, Nugent ST, Raj LK, Sobanko JF, et al
    Frequency and reliability of histologic subtype classification in invasive and in situ melanoma treated with Mohs micrographic surgery.
    J Am Acad Dermatol. 2023 Jan 17:S0190-9622(23)00082.
    PubMed    
    
    
    
72. BEAL BT, Udkoff J, Aizman L, Etzkorn J, et al
    Outcomes of invasive melanoma of the head and neck treated with Mohs Micrographic Surgery - a multicenter study.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00062.
    PubMed     Abstract available
    
    
    
73. OH BH, Lee S, Park JW, Lee JY, et al
    Risk of recurrence of nail unit melanoma after functional surgery versus amputation.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00063.
    PubMed     Abstract available
    
    
    
74. WOJCIK KY, Hawkins M, Anderson-Mellies A, Hall E, et al
    Melanoma Survival by Age Group: Population-Based Disparities for Adolescent and Young Adult Patients by Stage, Tumor Thickness, and Insurance Type.
    J Am Acad Dermatol. 2023 Jan 4:S0190-9622(23)00003.
    PubMed     Abstract available
    
    
    
75. SPACCARELLI N, Drozdowski R, Peters MS, Grant-Kels JM, et al
    Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
    J Am Acad Dermatol. 2023;88:13-20.
    PubMed     Abstract available
    
    
    
76. DROZDOWSKI R, Spaccarelli N, Peters MS, Grant-Kels JM, et al
    Dysplastic nevus part I: Historical perspective, classification, and epidemiology.
    J Am Acad Dermatol. 2023;88:1-10.
    PubMed     Abstract available
    
    
    
77. FARIES MB, Cochran AJ, Thompson JF
    Re: "Time to reconsider the role of sentinel lymph node biopsy in melanoma".
    J Am Acad Dermatol. 2023;88:e25-e26.
    PubMed    
    
    
    
78. BEAULIEU D, Tsao H, Michaud DS, Okhovat JP, et al
    Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010.
    J Am Acad Dermatol. 2023;88:60-70.
    PubMed     Abstract available
    
    
    December 2022
79. VALEK SA, Rousseau MA, Nelson KC, Kannler C, et al
    Melanoma risk among career firefighters: A systematic review of case-control studies.
    J Am Acad Dermatol. 2022 Dec 30:S0190-9622(22)03320.
    PubMed    
    
    
    
80. ROUSSET P, Dalle S, Mortier L, Dereure O, et al
    Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
    J Am Acad Dermatol. 2022 Dec 19:S0190-9622(22)03142.
    PubMed     Abstract available
    
    
    
81. HUERTA T, Swetter SM, Nehal KS, Coit DG, et al
    Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma.
    J Am Acad Dermatol. 2022 Dec 16:S0190-9622(22)03308.
    PubMed    
    
    
    
82. PEDERSEN EA, Harms PW, Zhao L, Andea AA, et al
    Polypoid melanoma is associated with aggressive histopathological characteristics and poor clinical prognosis: A retrospective cohort study.
    J Am Acad Dermatol. 2022 Dec 10:S0190-9622(22)03181.
    PubMed    
    
    
    
83. EL SHAROUNI MA, Rawson RV, Potter AJ, Paver EC, et al
    Melanomas in children and adolescents: clinicopathologic features and survival outcomes.
    J Am Acad Dermatol. 2022 Dec 9:S0190-9622(22)03176.
    PubMed     Abstract available
    
    
    November 2022
84. KREHER MA, Noland MMB, Konda S, Longo MI, et al
    Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids.
    J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03145.
    PubMed     Abstract available
    
    
    
85. KREHER MA, Konda S, Noland MMB, Longo MI, et al
    Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors.
    J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03146.
    PubMed     Abstract available
    
    
    
86. SHARON CE, Straker RJ 3rd, Gimotty PA, Chu EY, et al
    Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: a population-based analysis.
    J Am Acad Dermatol. 2022 Nov 25:S0190-9622(22)03133.
    PubMed     Abstract available
    
    
    
87. KNACKSTEDT T
    Differences in Sentinel Lymph Node Biopsy Utilization in Eligible Melanoma Patients Treated with Mohs Micrographic Surgery or Wide Local Excision: A population-based logistic regression model and survival analysis.
    J Am Acad Dermatol. 2022 Nov 8. pii: S0190-9622(22)02988.
    PubMed     Abstract available
    
    
    
88. VAN MOLLE P, Brochez L, Verbelen T, De Boom C, et al
    The value of measuring uncertainty in neural networks in dermoscopy.
    J Am Acad Dermatol. 2022;87:1191-1193.
    PubMed    
    
    
    
89. SEIVERLING EV, Stevens K, Dorr G, Prentiss MA, et al
    Impact of multimodal dermatoscopy training on skin biopsies by primary care providers.
    J Am Acad Dermatol. 2022;87:1119-1121.
    PubMed    
    
    
    October 2022
90. ROTH A, Boutko A, Lampley N 3rd, Olivares S, et al
    Indoor tanning is associated with an increased risk for multiple primary melanomas: A case-control study.
    J Am Acad Dermatol. 2022 Oct 30. pii: S0190-9622(22)02781.
    PubMed    
    
    
    
91. RIQUELME-MC LOUGHLIN C, Sandoval-Clavijo A, de Tord MB, Boada A, et al
    Prognostic role of microsatellites in melanoma and implications in the AJCC classification system: a cohort study.
    J Am Acad Dermatol. 2022 Oct 17. pii: S0190-9622(22)02898.
    PubMed     Abstract available
    
    
    
92. FERNANDEZ JM, Dahak S, Wysong A, Whitley MJ, et al
    Differences Between Asian Americans and Pacific Islanders with Cutaneous Melanoma: A Retrospective Cohort Analysis of 1,339 Cases.
    J Am Acad Dermatol. 2022 Oct 13. pii: S0190-9622(22)02887.
    PubMed    
    
    
    
93. FERNANDEZ JM, Mata EM, Behbahani S, Kwan KR, et al
    Survival of Hispanic Patients with Cutaneous Melanoma: A Retrospective Cohort Analysis of 6,016 Cases from the National Cancer Database.
    J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02806.
    PubMed    
    
    
    
94. ROSENTHAL A, Reddy S, Cooper R, Chung J, et al
    Disparities in Melanoma-Specific Mortality by Race/Ethnicity, Socioeconomic Status, and Healthcare Systems.
    J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02800.
    PubMed     Abstract available
    
    
    
95. LEE DK, Chang MJ, Desai AD, Lipner SR, et al
    Clinical and dermoscopic findings of benign longitudinal melanonychia due to melanocytic activation differ by skin type and predict likelihood of nail matrix biopsy.
    J Am Acad Dermatol. 2022;87:792-799.
    PubMed     Abstract available
    
    
    
96. JAIN M, Autuori I, Everett N, Harris U, et al
    Minimally invasive microbiopsy for genetic profiling of melanocytic lesions: A case series.
    J Am Acad Dermatol. 2022;87:903-904.
    PubMed    
    
    
    
97. DELLATORRE G, Gadens GA, Polo Silveira L, Kose K, et al
    Video-based wide area digital dermoscopy.
    J Am Acad Dermatol. 2022;87:e125-e126.
    PubMed    
    
    
    September 2022
98. SHANNON AB, Sharon CE, Straker RJ 3rd, Carr MJ, et al
    Sentinel Lymph Node Biopsy in Patients with T1a Cutaneous Malignant Melanoma: A Multi-Center Cohort Study.
    J Am Acad Dermatol. 2022 Sep 29. pii: S0190-9622(22)02783.
    PubMed     Abstract available
    
    
    
99. 
    The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe.
    J Am Acad Dermatol. 2022 Sep 24. pii: S0190-9622(22)02780.
    PubMed    
    
    
    
100. WEI X, Chen Y, Yao H, Wu D, et al
     Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
     J Am Acad Dermatol. 2022 Sep 5. pii: S0190-9622(22)02627.
     PubMed     Abstract available
     
     
     
101. KIM CG, Kim M, Hwang J, Kim ST, et al
     First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
     J Am Acad Dermatol. 2022 Sep 3. pii: S0190-9622(22)02443.
     PubMed     Abstract available
     
     
     
102. PHAM F, Boespflug A, Duru G, Phan A, et al
     Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
     J Am Acad Dermatol. 2022;87:551-558.
     PubMed     Abstract available
     
     
     
103. PHAM JP, Star P, Phan K, Loh Y, et al
     BRAF inhibition and the spectrum of granulomatous reactions.
     J Am Acad Dermatol. 2022;87:605-613.
     PubMed     Abstract available
     
     
     August 2022
104. FALOTICO JM, Postow MA, Lipner SR
     Standardized guidelines for acral and nail unit melanoma treatment are lacking.
     J Am Acad Dermatol. 2022 Aug 18. pii: S0190-9622(22)02548.
     PubMed    
     
     
     
105. CHERAGHLOU S, Doudican NA, Criscito MC, Stevenson ML, et al
     Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs micrographic surgery.
     J Am Acad Dermatol. 2022 Aug 17. pii: S0190-9622(22)02544.
     PubMed    
     
     
     
106. KOLLA AM, Seixas A, Adotama P, Foster V, et al
     A Health Equity Framework to Address Racial and Ethnic Disparities in Melanoma.
     J Am Acad Dermatol. 2022 Aug 12. pii: S0190-9622(22)02526.
     PubMed    
     
     
     
107. RAN NA, Nugent ST, Veerabagu S, Chu EY, et al
     Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery - rates of positive margins, local recurrence, and repeat surgeries.
     J Am Acad Dermatol. 2022 Aug 10. pii: S0190-9622(22)02450.
     PubMed    
     
     
     
108. FERNANDEZ JM, Bubic BN, Dahak S, Mata EM, et al
     Racial and Ethnic Differences in Tumor Characteristics and Overall Survival of Women with Melanoma: A National Cancer Database Retrospective Cohort Study.
     J Am Acad Dermatol. 2022 Aug 3. pii: S0190-9622(22)02413.
     PubMed    
     
     
     
109. MARCAILLOU M, Dion J, Baroudjian B, Ezrine E, et al
     Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
     J Am Acad Dermatol. 2022;87:e85-e88.
     PubMed    
     
     
     
110. LEE JS, Kim S, Kim DH, Lee JW, et al
     Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea.
     J Am Acad Dermatol. 2022;87:366-372.
     PubMed     Abstract available
     
     
     
111. PEREZ M, Abisaad JA, Rojas KD, Marchetti MA, et al
     Skin cancer: Primary, secondary, and tertiary prevention. Part I.
     J Am Acad Dermatol. 2022;87:255-268.
     PubMed     Abstract available
     
     
     July 2022
112. PAN CX, Yang K, Lau CB, Zhou G, et al
     Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.
     J Am Acad Dermatol. 2022 Jul 21. pii: S0190-9622(22)02400.
     PubMed    
     
     
     
113. JARELL A, Gastman BR, Dillon LD, Hsueh EC, et al
     Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.
     J Am Acad Dermatol. 2022 Jul 7. pii: S0190-9622(22)02253.
     PubMed     Abstract available
     
     
     
114. MULLIGAN KM, Cullison CR, Zheng DX, Rothermel LD, et al
     Mucosal melanoma and organ-specific metastasis: Differences in survival outcomes between tumor primary sites.
     J Am Acad Dermatol. 2022 Jul 5. pii: S0190-9622(22)02248.
     PubMed    
     
     
     
115. XIONG DD, Barriera-Silvestrini P, Knackstedt TJ
     Delays in surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: a population-based analysis.
     J Am Acad Dermatol. 2022 Jul 1. pii: S0190-9622(22)02239.
     PubMed     Abstract available
     
     
     June 2022
116. TREPANOWSKI N, Chang MS, Zhou G, Ahmad M, et al
     Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study.
     J Am Acad Dermatol. 2022 Jun 20. pii: S0190-9622(22)01023.
     PubMed    
     
     
     
117. CHOI ME, Won CH, Chang SE, Lee MW, et al
     Clinical and Prognostic Influence of Tumor Diameter in Acral Lentiginous Melanoma.
     J Am Acad Dermatol. 2022 Jun 17. pii: S0190-9622(22)01019.
     PubMed    
     
     
     
118. ELSTON DM
     Letter from the editor: Delays in Melanoma Diagnosis.
     J Am Acad Dermatol. 2022 Jun 16. pii: S0190-9622(22)01011.
     PubMed    
     
     
     
119. KUMAR AB, Peters MS, Jakub JW, Harmsen W, et al
     "Primary cutaneous melanoma features predict development of intransit metastases/satellite lesions: Mayo Clinic experience 2010-2014".
     J Am Acad Dermatol. 2022 Jun 13. pii: S0190-9622(22)00994.
     PubMed    
     
     
     
120. BLUMENTHAL LY, Hu JC
     Response to "Comment on 'Racial/Ethnic disparities in non-melanoma skin cancer based on Mohs micrographic surgery defect size, a multicenter retrospective study'".
     J Am Acad Dermatol. 2022 Jun 2. pii: S0190-9622(22)00902.
     PubMed    
     
     
     May 2022
121. KURN HA, Abercrombie M, Tzellos T, Dellavalle RP, et al
     From the Cochrane Library: Interventions for Melanoma in Situ, Including Lentigo Maligna.
     J Am Acad Dermatol. 2022 May 28. pii: S0190-9622(22)00889.
     PubMed    
     
     
     
122. SCHARF C, Brancaccio G, Di Stefani A, Fargnoli MC, et al
     THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE.
     J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00812.
     PubMed    
     
     
     
123. LUU YT, Goldstein AM, Sargen MR
     Variation in second cancer risk by melanoma subtype among survivors.
     J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00816.
     PubMed    
     
     
     
124. SHAIKH SS, Yang X, Fortman DD, Wang H, et al
     A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma.
     J Am Acad Dermatol. 2022 May 9. pii: S0190-9622(22)00798.
     PubMed    
     
     
     
125. BRUNSGAARD E, Wu YP, Grossman D
     Melanoma in Skin of Color: Part I. Epidemiology and clinical presentation.
     J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00783.
     PubMed     Abstract available
     
     
     
126. BRUNSGAARD E, Jensen J, Grossman D
     Melanoma in Skin of Color: Part II. Racial disparities, role of UV, and interventions for earlier detection.
     J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00784.
     PubMed     Abstract available
     
     
     
127. SARVER MM, Rames JD, Beasley GM, Gao J, et al
     Survival and Tumor Characteristics of Patients Presenting with Single Primary vs. Second Primary Melanoma Lesions.
     J Am Acad Dermatol. 2022 May 4. pii: S0190-9622(22)00715.
     PubMed     Abstract available
     
     
     
128. CONDORELLI AG, Farnetani F, Ciardo S, Chester J, et al
     Dynamic dermoscopic and reflectance confocal microscopic changes of melanocytic lesions excised during follow up.
     J Am Acad Dermatol. 2022;86:1049-1057.
     PubMed     Abstract available
     
     
     
129. SOENEN A, Vourc'h M, Khammari A, Nguyen JM, et al
     Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
     J Am Acad Dermatol. 2022;86:1042-1048.
     PubMed     Abstract available
     
     
     April 2022
130. MORAES AFA, Blumetti TCMP, Pinto C, Bertoli E, et al
     Melanoma with peripheral globules: clinical and dermoscopic features.
     J Am Acad Dermatol. 2022 Apr 26. pii: S0190-9622(22)00697.
     PubMed     Abstract available
     
     
     
131. STRAKER RJ 3RD, Sharon CE, Chu EY, Miura JT, et al
     Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.
     J Am Acad Dermatol. 2022 Apr 22. pii: S0190-9622(22)00681.
     PubMed     Abstract available
     
     
     March 2022
132. HOBAYAN CGP, Grant-Kels JM, Korman AM
     The ethics of dismissing a melanoma patient who repeatedly no-shows.
     J Am Acad Dermatol. 2022 Mar 19. pii: S0190-9622(22)00504.
     PubMed    
     
     
     
133. CHANG MS, La J, Trepanowski N, Cheng D, et al
     Increased relative proportions of advanced melanoma among Veterans: a comparative analysis with the SEER registry.
     J Am Acad Dermatol. 2022 Mar 9. pii: S0190-9622(22)00392.
     PubMed     Abstract available
     
     
     
134. WONGVIBULSIN S, Pahalyants V, Kalinich M, Murphy W, et al
     Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
     J Am Acad Dermatol. 2022;86:563-572.
     PubMed     Abstract available
     
     
     February 2022
135. ASDOURIAN MS, Otto TS, Jacoby TV, Shah N, et al
     Association between serum LDH and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
     J Am Acad Dermatol. 2022 Feb 19. pii: S0190-9622(22)00335.
     PubMed    
     
     
     
136. EL SHAROUNI MA, Rawson RV, Sigurdsson V, Witkamp AJ, et al
     The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (>/=15mm in thickness).
     J Am Acad Dermatol. 2022 Feb 1. pii: S0190-9622(22)00174.
     PubMed     Abstract available
     
     
     January 2022
137. PRASAD S, Black S, Chen HW, Joseph A, et al
     Beliefs and barriers to care of primary care practitioners towards melanoma screening and education in rural Texas.
     J Am Acad Dermatol. 2022 Jan 22. pii: S0190-9622(22)00091.
     PubMed    
     
     
     
138. MUZUMDAR S, Wu R, Rothe MJ, Grant-Kels JM, et al
     Reflectance confocal microscopy decreases the cost of skin lesion diagnosis: A single institution retrospective chart review.
     J Am Acad Dermatol. 2022;86:209-211.
     PubMed    
     
     
     December 2021
139. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
     Melanoma: How and When to Consider Clinical Diagnostic Technologies.
     J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02971.
     PubMed     Abstract available
     
     
     
140. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
     Melanoma: An Update on Systemic Therapies.
     J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02970.
     PubMed     Abstract available
     
     
     
141. GOLDSMITH SM
     Comment on "Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas".
     J Am Acad Dermatol. 2021;85:e361.
     PubMed    
     
     
     
142. VASICEK B, Erickson T, Lake E
     Comment on "Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation".
     J Am Acad Dermatol. 2021;85:e351.
     PubMed    
     
     
     
143. MONTAGNER S
     Reply to: "Comment on 'Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation'".
     J Am Acad Dermatol. 2021;85:e353.
     PubMed    
     
     
     
144. OKHOVAT JP, Davine JA, Hawryluk EB, Geller AC, et al
     Educational brochure impact on postscreening practices of American Academy of Dermatology skin cancer screening participants.
     J Am Acad Dermatol. 2021;85:1616-1617.
     PubMed    
     
     
     
145. ZAKHEM GA, Fakhoury JW, Motosko CC, Ho RS, et al
     Characterizing the role of dermatologists in developing artificial intelligence for assessment of skin cancer.
     J Am Acad Dermatol. 2021;85:1544-1556.
     PubMed     Abstract available
     
     
     November 2021
146. KURN HA, Sivesind TE, Dellavalle RP
     From the Cochrane Library: Screening for Reducing Morbidity and Mortality in Malignant Melanoma.
     J Am Acad Dermatol. 2021 Nov 25. pii: S0190-9622(21)02909.
     PubMed    
     
     
     
147. RAVAL NS, Hodges WT, Ugwu-Dike PO, Godoy F, et al
     Racial and socioeconomic differences in acral lentiginous melanoma outcomes: a SEER analysis.
     J Am Acad Dermatol. 2021 Nov 20. pii: S0190-9622(21)02856.
     PubMed    
     
     
     
148. THORPE RB, Covington KR, Caruso HG, Quick AP, et al
     Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.
     J Am Acad Dermatol. 2021 Nov 19. pii: S0190-9622(21)02854.
     PubMed     Abstract available
     
     
     
149. KANTOR J
     This Month in JAAD International: February 2022: Vitiligo in melanoma patients treated with anti-PD-1 therapies and improved survival.
     J Am Acad Dermatol. 2021 Nov 6. pii: S0190-9622(21)02749.
     PubMed    
     
     
     
150. SOENEN A, Vourc'h M, Dreno B, Chiaverini C, et al
     Diagnosis of congenital pigmented macules in infants with reflectance confocal microscopy and machine learning.
     J Am Acad Dermatol. 2021;85:1308-1309.
     PubMed    
     
     
     
151. MAZMUDAR RS, Fazio J, Garland K, Tripathi R, et al
     Predictors of patient-initiated communication after Mohs micrographic surgery: A multi-institutional prospective cohort study.
     J Am Acad Dermatol. 2021;85:1290-1293.
     PubMed    
     
     
     
152. GOMEZ-MARTIN I, Collgros H, Ferguson PM, Barreiro A, et al
     Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques.
     J Am Acad Dermatol. 2021;85:1151-1160.
     PubMed     Abstract available
     
     
     
153. TRIPATHI R, Bordeaux JS, Nijhawan RI
     Utilization of palliative therapy for metastatic melanoma in the United States.
     J Am Acad Dermatol. 2021;85:1342-1345.
     PubMed    
     
     
     
154. CHANG MS, Huang L, Mostaghimi A, Hartman RI, et al
     Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening.
     J Am Acad Dermatol. 2021;85:1326-1328.
     PubMed    
     
     
     October 2021
155. FARAH M, Chung HJ
     Diagnostic Utility of PRAME Immunohistochemistry in the Evaluation of Melanomas with a Co-existent Nevoid Melanocytic Population: A Single Center Retrospective Cohort Study.
     J Am Acad Dermatol. 2021 Oct 28. pii: S0190-9622(21)02714.
     PubMed    
     
     
     
156. IPENBURG NA, El Sharouni MA, van Doorn R, van Diest PJ, et al
     Lack of association between CDKN2A germline mutations and survival in melanoma patients: a retrospective cohort study.
     J Am Acad Dermatol. 2021 Oct 22. pii: S0190-9622(21)02677.
     PubMed    
     
     
     
157. LIN JQ, Li SQ, Li S, Kiamanesh EF, et al
     A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients.
     J Am Acad Dermatol. 2021 Oct 11. pii: S0190-9622(21)02632.
     PubMed     Abstract available
     
     
     
158. LITCHMAN GH, Teplitz RW, Marson JW, Rigel DS, et al
     Impact of electrical impedance spectroscopy on dermatologists' number needed to biopsy metric and biopsy decisions for pigmented skin lesions.
     J Am Acad Dermatol. 2021;85:976-979.
     PubMed    
     
     
     September 2021
159. GAGHAN LJ, Bui H, Lipner SR, Jellinek NJ, et al
     Evaluation of a community education tool for detection of nail melanoma by nail salon technicians.
     J Am Acad Dermatol. 2021 Sep 21. pii: S0190-9622(21)02503.
     PubMed    
     
     
     
160. BLUMENTHAL LY, Arzeno J, Syder N, Rabi S, et al
     Disparities in non-melanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size, a multicenter retrospective study.
     J Am Acad Dermatol. 2021 Sep 4. pii: S0190-9622(21)02423.
     PubMed     Abstract available
     
     
     
161. LALLAS A, Kyrgidis A, Manoli SM, Papageorgiou C, et al
     Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: Data from an institutional registry.
     J Am Acad Dermatol. 2021;85:721-723.
     PubMed    
     
     
     August 2021
162. MCFEELY O, Hollywood A, Stanciu M, O'Connell M, et al
     Comment on "The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience".
     J Am Acad Dermatol. 2021 Aug 28. pii: S0190-9622(21)02383.
     PubMed    
     
     
     
163. STRAKER RJ 3RD, Kelly N, Sharon CE, Shannon AB, et al
     Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis.
     J Am Acad Dermatol. 2021 Aug 12. pii: S0190-9622(21)02299.
     PubMed    
     
     
     
164. YAN BY, Barilla S, Strunk A, Garg A, et al
     Survival Differences in Acral Lentiginous Melanoma According to Socioeconomic Status and Race.
     J Am Acad Dermatol. 2021 Aug 4. pii: S0190-9622(21)02210.
     PubMed     Abstract available
     
     
     
165. PARISI R, Huppertz J, Potolski A, Tracey V, et al
     Distance to Diagnosing Dermatology Provider as a Predictor of Multiple Melanoma Diagnoses.
     J Am Acad Dermatol. 2021 Aug 3. pii: S0190-9622(21)02214.
     PubMed    
     
     
     
166. KANTOR J
     August 2021: On the epistemology of Breslow thickness and histopathologic melanoma subtype.
     J Am Acad Dermatol. 2021;85:318.
     PubMed    
     
     
     
167. WANG TS, Griffiths CC, Roman EM
     Should topical imiquimod be used for positive margins in lentigo maligna?
     J Am Acad Dermatol. 2021;85:521-522.
     PubMed    
     
     
     July 2021
168. GAUDY-MARQUESTE C, Macagno N, Loundou A, Pellegrino E, et al
     Molecular characterization of fast-growing melanomas.
     J Am Acad Dermatol. 2021 Jul 16. pii: S0190-9622(21)02101.
     PubMed     Abstract available
     
     
     
169. BUI AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al
     Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
     J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02087.
     PubMed    
     
     
     
170. STRAKER RJ 3RD, Thaler AS, Shannon AB, Miura JT, et al
     Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis.
     J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02095.
     PubMed    
     
     
     June 2021
171. YOO H, Kim H, Kwon ST, Jo SJ, et al
     Tumor invasion in the hyponychium is associated with distant metastasis and poor prognosis in subungual melanoma: A histological landscape of 44 cases.
     J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01989.
     PubMed     Abstract available
     
     
     
172. CARLET C, Dalle S, Leccia MT, Mortier L, et al
     Late-onset adverse events under anti-PD1 therapy in melanoma patients: an observational study from MELBASE, a nationwide prospective cohort.
     J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01991.
     PubMed     Abstract available
     
     
     
173. FIGUEROA-SILVA O, Suarez-Penaranda JM, Balboa-Barreiro V, Rojas SA, et al
     Volume tumor impact on melanoma survival assessed through Breslow density.
     J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01107.
     PubMed    
     
     
     
174. MUZUMDAR S, Lin G, Kerr P, Grant-Kels JM, et al
     Is Melanoma Overdiagnosed? A Review of the Evidence.
     J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01110.
     PubMed     Abstract available
     
     
     
175. BEAULIEU D, Gao DX, Swetter SM, Hawryluk EB, et al
     Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer(R) screening program - A cross-sectional analysis.
     J Am Acad Dermatol. 2021 Jun 2. pii: S0190-9622(21)01044.
     PubMed    
     
     
     
176. VAIDYA TS, Bander TS, Musthaq S, Lampley N 3rd, et al
     Validation of a patient decision aid for the treatment of lentigo maligna.
     J Am Acad Dermatol. 2021;84:1751-1753.
     PubMed    
     
     
     
177. HANLON KL, Correa-Selm LM, Grichnik JM
     Application of 3-dimensional reflectance confocal microscopy: Melanocytic proliferations as three-dimensional models.
     J Am Acad Dermatol. 2021;84:1737-1739.
     PubMed    
     
     
     
178. ELSTON D
     This Month in JAAD: June 2021.
     J Am Acad Dermatol. 2021;84:1542.
     PubMed    
     
     
     
179. LONGO C, Mazzeo M, Raucci M, Cornacchia L, et al
     Dark pigmented lesions: Diagnostic accuracy of dermoscopy and reflectance confocal microscopy in a tertiary referral center for skin cancer diagnosis.
     J Am Acad Dermatol. 2021;84:1568-1574.
     PubMed     Abstract available
     
     
     May 2021
180. GREEN AC, Hughes MCB, Williams GM, Malt M, et al
     Increased melanoma recurrence in patients with multiple primary invasive melanomas.
     J Am Acad Dermatol. 2021 May 27. pii: S0190-9622(21)01012.
     PubMed    
     
     
     
181. BITTAR PG, Bittar JM, Etzkorn JR, Brewer JD, et al
     Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision.
     J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00937.
     PubMed     Abstract available
     
     
     
182. CHANG MS, Hartman RI
     Melanoma healthcare and outcome disparities in the Veteran Affairs population.
     J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00938.
     PubMed    
     
     
     April 2021
183. DUNCAN JR, Srikakolapu S, Daugherty A, Elston C, et al
     Cost Efficacy of Wide Local Excision of pT1a Melanoma in Office vs. Operating Room Settings.
     J Am Acad Dermatol. 2021 Apr 28. pii: S0190-9622(21)00920.
     PubMed    
     
     
     
184. GRANT-KELS JM
     JAAD Game Changers: Comparison of surgical margins for lentigo maligna versus melanoma in situ.
     J Am Acad Dermatol. 2021 Apr 21. pii: S0190-9622(21)00887.
     PubMed    
     
     
     
185. MILLER CJ, Etzkorn JR, Leitenberger JJ, Bar A, et al
     Commentary on "Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting".
     J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00770.
     PubMed    
     
     
     
186. ADALSTEINSSON JA, Stoj VJ, Algzlan H, Swede H, et al
     Limitations in the Literature Regarding Mohs Surgery and Staged Excision for Melanoma: A Critical Review of Quality and Data Reporting.
     J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00772.
     PubMed     Abstract available
     
     
     
187. AGGARWAL P, Knabel P, Fleischer AB Jr
     United States Burden of Melanoma and Non-Melanoma Skin Cancer from 1990 to 2019.
     J Am Acad Dermatol. 2021 Apr 11. pii: S0190-9622(21)00755.
     PubMed     Abstract available
     
     
     
188. OLAMIJU B, Suozzi KC, Leffell DJ, Christensen SR, et al
     Clinical Factors Impacting Clear Margins of Primary Melanoma in Situ with Conventional Excision in a Retrospective Cohort.
     J Am Acad Dermatol. 2021 Apr 10. pii: S0190-9622(21)00764.
     PubMed    
     
     
     
189. HEYMANN WR
     Melanoma Healthcare and Outcome Disparities: You Can Never Be Too Rich or Too Thin.
     J Am Acad Dermatol. 2021 Apr 3. pii: S0190-9622(21)00679.
     PubMed    
     
     
     
190. LUKOWIAK TM, Perz AM, Aizman L, Kovell RC, et al
     Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.
     J Am Acad Dermatol. 2021;84:1030-1036.
     PubMed     Abstract available
     
     
     
191. WILLIAMS EA, Shah N, Danziger N, Montesion M, et al
     Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
     J Am Acad Dermatol. 2021;84:1069-1071.
     PubMed    
     
     
     
192. MURZAKU EC, Shi K, Srivastava D, Nijhawan RI, et al
     Surgical management and practices in pregnancy and lactation: A survey of United States dermatologic surgeons.
     J Am Acad Dermatol. 2021;84:1134-1136.
     PubMed    
     
     
     
193. EASON CD, Rundle C, Dunnick CA, Hugh J, et al
     National trends in free public sunscreen dispensers.
     J Am Acad Dermatol. 2021;84:1109-1111.
     PubMed    
     
     
     March 2021
194. BAYERS S, Orseth M, Prasad S, Hynan LS, et al
     Community-based melanoma screening: A pilot study for the development of an educational curriculum for nonphysician providers.
     J Am Acad Dermatol. 2021 Mar 29. pii: S0190-9622(21)00362.
     PubMed    
     
     
     
195. THOMPSON LL, Chang MS, Polyakov NJ, Blum AE, et al
     Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
     J Am Acad Dermatol. 2021 Mar 12. pii: S0190-9622(21)00563.
     PubMed    
     
     
     
196. CULLISON CR, Tripathi R, Bordeaux JS
     Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma.
     J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00466.
     PubMed    
     
     
     
197. PITNEY T, Muir DJ
     Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
     J Am Acad Dermatol. 2021;84:861-862.
     PubMed    
     
     
     
198. MILLER RC, Stewart CR, Lipner SR
     Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19.
     J Am Acad Dermatol. 2021;84:777-779.
     PubMed    
     
     
     February 2021
199. KOBLINSKI JE, Maykowski P, Zeitouni NC
     Disparities in melanoma stage at diagnosis in Arizona: A 10-Year Arizona Cancer Registry Study.
     J Am Acad Dermatol. 2021 Feb 20. pii: S0190-9622(21)00404.
     PubMed    
     
     
     
200. GILLSTEDT M, Hedlund E, Paoli J, Polesie S, et al
     Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network.
     J Am Acad Dermatol. 2021 Feb 12. pii: S0190-9622(21)00336.
     PubMed    
     
     
     
201. BRINKER TJ, Schmitt M, Krieghoff-Henning EI, Barnhill R, et al
     Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists.
     J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00331.
     PubMed    
     
     
     
202. GONZALEZ-CAO M, Carrera C, Rodriguez Moreno JF, Rodriguez-Jimenez P, et al
     COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
     J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00337.
     PubMed    
     
     
     
203. STRAKER RJ 3RD, Song Y, Shannon AB, Chu EY, et al
     Association of the Affordable Care Act's Medicaid Expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database Study.
     J Am Acad Dermatol. 2021 Feb 4. pii: S0190-9622(21)00308.
     PubMed     Abstract available
     
     
     
204. VOGEL RI, Jewett PI, Ahmed RL, Lazovich D, et al
     Comparison of sun exposure and protection behaviors between urban and rural residents without a history of melanoma in the Midwestern United States.
     J Am Acad Dermatol. 2021 Feb 3. pii: S0190-9622(21)00304.
     PubMed    
     
     
     
205. LALLAS A, Lallas K, Tschandl P, Kittler H, et al
     The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis.
     J Am Acad Dermatol. 2021;84:381-389.
     PubMed     Abstract available
     
     
     January 2021
206. POLESIE S, Gillstedt M
     Psoriasis and risk of cutaneous melanoma: a retrospective comparative registry-based cohort study.
     J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00244.
     PubMed    
     
     
     
207. SCHWAB G, Gerami P, Fiessinger L, Nardone B, et al
     A comparison of the Breslow depth and all-cause survival of male and female genital melanomas.
     J Am Acad Dermatol. 2021 Jan 28. pii: S0190-9622(21)00216.
     PubMed    
     
     
     
208. TAN A, Greenwald E, Bajaj S, Belen D, et al
     Melanoma surveillance for high-risk patients via telemedicine: Examination of real-world data from an integrated store-and-forward total body photography and dermoscopy service.
     J Am Acad Dermatol. 2021 Jan 27. pii: S0190-9622(21)00206.
     PubMed    
     
     
     
209. NADELMAN DA, Ahn JW, VanKoevering KK, Smith NR, et al
     Research Letter: A Single Institution's Review of Patterns of Compliance with Melanoma Ultrasound Surveillance Recommendations.
     J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00225.
     PubMed    
     
     
     
210. HU X, Kilgour JM, Fogel AL, Jia JL, et al
     Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S. Cohort Study.
     J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00191.
     PubMed    
     
     
     
211. VARGAS-MORA P, Peruilh-Bagolini L, Gonzalez-Cuevas R, Ferrer-Rosende P, et al
     Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis.
     J Am Acad Dermatol. 2021 Jan 16. pii: S0190-9622(21)00162.
     PubMed     Abstract available
     
     
     
212. BHATT MD, Perz AM, Moioli E, Sobanko JF, et al
     The accuracy of detecting melanoma on frozen section MART-1 stains and on permanent sections of previously-frozen tissue: a prospective cohort study.
     J Am Acad Dermatol. 2021 Jan 13. pii: S0190-9622(21)00008.
     PubMed    
     
     
     
213. WEI C, Allais B, Tornberg HN, Quan T, et al
     The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media.
     J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00084.
     PubMed    
     
     
     
214. MARSON JW, Maner BS, Harding TP, Meisenheimer J VII, et al
     The Magnitude of COVID-19's Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers.
     J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00082.
     PubMed    
     
     
     
215. HARTMAN RI, La J, Chang MS, Cheng D, et al
     Risk factors for thick melanoma among Veterans: A cross-sectional study.
     J Am Acad Dermatol. 2021 Jan 7. pii: S0190-9622(21)00086.
     PubMed    
     
     
     
216. MOUSTAFA D, Duncan LM, Hawryluk EB
     A 20-year histopathologic study of pediatric nevi at an academic institution.
     J Am Acad Dermatol. 2021;84:39-40.
     PubMed    
     
     
     
217. LEWINSON RT, Meyers DE, Vallerand IA, Suo A, et al
     Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
     J Am Acad Dermatol. 2021;84:183-185.
     PubMed    
     
     
     
218. NAVARRETE-DECHENT C, Liopyris K, Monnier J, Aleissa S, et al
     Reflectance confocal microscopy terminology glossary for melanocytic skin lesions: A systematic review.
     J Am Acad Dermatol. 2021;84:102-119.
     PubMed     Abstract available
     
     
     December 2020
219. SHANNON AB, Sharon CE, Straker RJ 3rd, Miura JT, et al
     The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience.
     J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33225.
     PubMed    
     
     
     
220. MIGUEL BAF, Morgado-Carrasco D, Toll A, Perez-Anker J, et al
     Meshed keystone flap: A last-step modification to reduce tension and cover a larger surface.
     J Am Acad Dermatol. 2020;83:e397-e398.
     PubMed    
     
     
     November 2020
221. DIKA E, Mastroeni S, Lambertini M, Scarfi F, et al
     The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study.
     J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33097.
     PubMed    
     
     
     
222. ALLAIS BS, Beatson M, Wang H, Shahbazi S, et al
     Five-Year Survival in Patients with Nodular and Superficial Spreading Melanomas in the US Population.
     J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33094.
     PubMed     Abstract available
     
     
     
223. BARRIOS DM, Do MH, Phillips GS, Postow MA, et al
     Immune checkpoint inhibitors to treat cutaneous malignancies.
     J Am Acad Dermatol. 2020;83:1239-1253.
     PubMed     Abstract available
     
     
     October 2020
224. BEHBAHANI S, Malerba S, Maniar A, Taback B, et al
     Outcomes and Predictors of Survival in Cutaneous Melanoma of the Eyelid: An Analysis of the National Cancer Database.
     J Am Acad Dermatol. 2020 Oct 31. pii: S0190-9622(20)32903.
     PubMed    
     
     
     
225. KELM RC, Ali Y, Orrell K, Rangel SM, et al
     Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
     J Am Acad Dermatol. 2020 Oct 24. pii: S0190-9622(20)32862.
     PubMed    
     
     
     
226. NAVARRETE-DECHENT C, Aleissa S, Connolly K, Hibler BP, et al
     Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
     J Am Acad Dermatol. 2020 Oct 20. pii: S0190-9622(20)32835.
     PubMed     Abstract available
     
     
     
227. SISCOS SM, Neill BC, Seger EW, Rajpara A, et al
     Practice habits of Mohs surgeons treating melanoma with Mohs surgery: a cross-sectional survey.
     J Am Acad Dermatol. 2020 Oct 3. pii: S0190-9622(20)32682.
     PubMed    
     
     
     
228. SHI K, Kim D, Mohan LS, Garfield EM, et al
     A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy.
     J Am Acad Dermatol. 2020;83:1028-1034.
     PubMed     Abstract available
     
     
     
229. KINSER K, Barlow CE, Leonard D, Farrell SW, et al
     Tanning bed use and depression in a preventive medicine cohort: The Cooper Center Longitudinal Study.
     J Am Acad Dermatol. 2020;83:1200-1202.
     PubMed    
     
     
     
230. YELAMOS O, Manubens E, Jain M, Chavez-Bourgeois M, et al
     Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers.
     J Am Acad Dermatol. 2020;83:1057-1063.
     PubMed     Abstract available
     
     
     July 2020
231. SOLEYMANI T, Swetter SM, Hollmig ST, Aasi SZ, et al
     Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
     J Am Acad Dermatol. 2020;83:254-255.
     PubMed    
     
     
     June 2020
232. JAFRY MA, Peacock S, Radick AC, Shucard HL, et al
     Pathologists' agreement on treatment suggestions for melanocytic skin lesions.
     J Am Acad Dermatol. 2020;82:1435-1444.
     PubMed     Abstract available
     
     
     May 2020
233. PEREZ-ANKER J, Puig S, Malvehy J
     A fast and effective option for tissue flattening: Optimizing time and efficacy in ex vivo confocal microscopy.
     J Am Acad Dermatol. 2020;82:e157-e158.
     PubMed    
     
     
     April 2020
234. FRIEDMAN BJ, Lee JB
     Spitz nevi in older adults: Correlation of histopathology with results of a gene expression profiling assay.
     J Am Acad Dermatol. 2020;82:1021-1023.
     PubMed    
     
     
     
235. BATCHELDER E, Straight C, Butt M, Kirby JS, et al
     Information framing effects on patients' decisions about dysplastic nevus management.
     J Am Acad Dermatol. 2020;82:1011-1013.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: